Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 830.55 | 1139.67 | 1981.73 | 0.5743 | 0.2824 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 830.55 | 874.33 | 1981.73 | 0.4402 | 0.0361 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 830.55 | 800.33 | 1981.73 | 0.4038 | -0.0303 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 830.55 | 718.50 | 1981.73 | 0.3623 | -0.1115 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2066.50 | 1981.73 | 1.0428 | 1.0662 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1907.67 | 1981.73 | 0.9626 | 0.9377 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2279.17 | 1981.73 | 1.1504 | 1.2368 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 2084.33 | 1981.73 | 1.0529 | 1.0841 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 2067.83 | 1981.73 | 1.0440 | 1.0697 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 1250.00 | 830.55 | 1913.67 | 1981.73 | 0.9651 | 0.9413 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1470.83 | 1981.73 | 0.7418 | 0.5750 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 1250.00 | 830.55 | 923.50 | 1981.73 | 0.4663 | 0.0882 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1088.00 | 1981.73 | 0.5492 | 0.2390 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 830.55 | 1972.50 | 1981.73 | 0.9969 | 0.9964 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 1833.67 | 1981.73 | 0.9251 | 0.8787 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1676.67 | 1981.73 | 0.8464 | 0.7512 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 1258.83 | 1981.73 | 0.6353 | 0.3914 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1082.17 | 1981.73 | 0.5463 | 0.2339 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 885.83 | 1981.73 | 0.4470 | 0.0515 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 1250.00 | 830.55 | 796.33 | 1981.73 | 0.4016 | -0.0348 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 829.33 | 1981.73 | 0.4174 | -0.0058 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 1250.00 | 830.55 | 626.67 | 1981.73 | 0.3149 | -0.2071 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2205.83 | 1981.73 | 1.1125 | 1.1761 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 2105.67 | 1981.73 | 1.0630 | 1.1000 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2248.17 | 1981.73 | 1.1339 | 1.2095 |